Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis

NCT02025725 is registered in ClinicalTrials.gov with Evoke Pharma as lead sponsor.

NCT NCT02025725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02025725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis
Lead sponsor
Evoke Pharma
Phase
Phase 3
Overall status
Completed
Start date
March 27, 2014
Completion date
June 27, 2016
Enrollment
205 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic gastroparesis